Please use this identifier to cite or link to this item: https://hdl.handle.net/1/2710
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLing, Ryan Ruiyang-
dc.contributor.authorPonnapa Reddy, Mallikarjuna-
dc.contributor.authorSubramaniam, Ashwin-
dc.contributor.authorMoran, Benjamin L-
dc.contributor.authorRamanathan, Kollengode-
dc.contributor.authorRamanan, Mahesh-
dc.contributor.authorBurrell, Aidan-
dc.contributor.authorPilcher, David-
dc.contributor.authorShekar, Kiran-
dc.date.accessioned2024-09-05T00:30:03Z-
dc.date.available2024-09-05T00:30:03Z-
dc.date.issued2024-09-02-
dc.identifier.citationOnline ahead of printen
dc.identifier.urihttps://hdl.handle.net/1/2710-
dc.description.abstractAcute hypoxaemic respiratory failure (AHRF) is a common reason for intensive care unit (ICU) admission. However, patient characteristics, outcomes, and trends over time are unclear. We describe the epidemiology and outcomes of patients with AHRF over time. In this binational, registry-based study from 2005 to 2022, we included all adults admitted to an Australian or New Zealand ICU with an arterial blood gas within the first 24 h of ICU stay. AHRF was defined as a partial pressure of oxygen/inspired oxygen ratio (PaO2/FiO2) ≤ 300. The primary outcome was adjusted in-hospital mortality, categorised based on PaO2/FiO2 (mild: 200-300, moderate: 100-200, and severe < 100, and non-linearly). We investigated how adjusted mortality evolved based on temporal trends (by year of admission), sex, age, admission diagnosis and the receipt of mechanical ventilation. Of 1,560,221 patients, 826,106 (52.9%) were admitted with or developed AHRF within the first 24 h of ICU stay. Of these 826,106 patients, 51.4% had mild, 39.3% had moderate, and 9.3% had severe AHRF. Compared to patients without AHRF (5.3%), patients with mild (8%), moderate (14.2%) and severe (29.9%) AHRF had higher in-hospital mortality rates. As PaO2/FiO2 ratio decreased, adjusted in-hospital mortality progressively increased, particularly below an inflection point at a PaO2/FiO2 ratio of 200. The adjusted in-hospital mortality for all patients decreased over time (13.3% in 2005 to 8.2% in 2022), and this trend was similar in patients with and without AHRF. The healthcare burden due to AHRF may be larger than expected, and mortality rates remain high in severe AHRF. Although mortality has decreased over time, this may reflect improvements in ICU care in general, rather than specifically in AHRF. More research is required to earlier identify AHRF and stratify these patients at risk of deterioration early, and to validate our findings.en
dc.description.sponsorshipIntensive Careen
dc.subjectIntensive Careen
dc.titleEpidemiology of acute hypoxaemic respiratory failure in Australian and New Zealand intensive care units during 2005-2022. A binational, registry-based studyen
dc.typeJournal Articleen
dc.identifier.doi10.1007/s00134-024-07609-yen
dc.description.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/39222135en
dc.description.affiliatesCentral Coast Local Health Districten
dc.description.affiliatesGosford Hospitalen
dc.identifier.journaltitleIntensive Care Medicineen
dc.type.contentTexten
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
Appears in Collections:Health Service Research
Show simple item record

Page view(s)

12
checked on Oct 10, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.